Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03241927
Title Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nina Bhardwaj
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field